Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysis

BACKGROUND: Currently, there is no consensus on the efficacy and resistance of de novo combination therapy versus monotherapy for treatment naive patients of chronic hepatitis B (CHB). OBJECTIVES: The aim of this study was to evaluate the effectiveness and resistance of de novo combination of lamivu...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fen, Wang, Xiwei, Wei, Fang, Hu, Huaidong, Zhang, Dazhi, Hu, Peng, Ren, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986697/
https://www.ncbi.nlm.nih.gov/pubmed/24673792
http://dx.doi.org/10.1186/1743-422X-11-59

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986697/
https://www.ncbi.nlm.nih.gov/pubmed/24673792
http://dx.doi.org/10.1186/1743-422X-11-59

Ejemplares similares